咨询电话:0571-88254427

Artificial intelligence (AI) in action: a cross-continental survey of AI adoption among field epidemiology fellows in Canada, the United States, and Europe, 2024

访问量:

BACKGROUND

Technologies available for applied public health practice are rapidly evolving. Artificial intelligence (AI) tools have become more accessible, however, their utilisation by field epidemiologists has not been described.

AIM

We explored AI use among Canadian, European, and United States (US) Field Epidemiology Training Program (FETP) fellows.

METHODS

Fellows in the three programmes (n = 220) were invited to an online survey available from 25 November 2024 to 5 December 2024. Quantitative and qualitative data were collected concerning the AI platforms fellows used, AI applications, comfort level when applying AI, use frequency, impact on work, barriers, ethical concerns, AI policy/guideline availability, and AI training.

RESULTS

There were 105 (48%) survey respondents: 13, 56 and 36 in the Canadian, US and European FETPs respectively. The proportion of respondents who reported applying AI for work was 66% (69/105) overall, and highest among respondents of the European programme (32/36). The most adopted platform was ChatGPT (60/69; 87%), and the most common application was analytical coding assistance (63/69; 91%). Among AI users, most felt somewhat comfortable (34/69; 49%) or comfortable (24/69; 35%) with AI and reported weekly (29/69; 42%) or daily (21/69; 30%) use. Generally, AI’s reported impact was positive. Challenges included technical difficulties, accuracy concerns, bias introduction, uncertainty regarding permissible uses, and data privacy issues. Among respondents, 47% (49/105) affirmed having AI policies/guidelines in their institutions and 20% (21/105) had received AI training.

CONCLUSION

To further incorporate AI use among its fellows, FETPs should monitor AI’s evolving role, and provide guidance and adapt curricula accordingly.

杭州纽罗西敏生物科技有限公司,您身边的多重PCR专家,专注于新型阵列式测序,检测,分析,流行病学调查平台。

地    址:杭州市教工路316号

电    话:0571-88254427

邮    箱:info@neuro-hemin.com

版权所有◎2023  杭州纽罗西敏生物科技有限公司      浙公网安备 33010602003287号     备案号:浙ICP备05030176号-1